StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.66−0.30 (-0.78%)

Close on Nov 20, 2026Market cap $27.92BP/E –Yield –

Roivant Sciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Roivant Sciences

Roivant Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Roivant Sciences figures

See a number that looks wrong?